If you have a prescription drug plan that is fulfilled by CVS/Caremark, several MS drugs will soon be excluded. CVS will still carry the medication, but it is dropping it from the formulary for insurance purposes. Since 2012, the list of excluded drugs has ballooned from 34 to 124 in 2016. Similarly, CVS's bigger prescription drug insurance rival Express-Scripts (ESRX) has banned 90 drugs from its coverage.
Most of the press coverage is about Viagra also being excluded.
Here are the MS drugs that CVS is dropping from its coverage in 2016:
Other drugs that will be excluded in 2016 include:
Most of the press coverage is about Viagra also being excluded.
Here are the MS drugs that CVS is dropping from its coverage in 2016:
- Avonex
- Extavia
- Plegridy
Other drugs that will be excluded in 2016 include:
- Abilify (antipsychotic)
- Amitiza (irritable bowel disease)
- Bydureon (diabetes)
- Carac (dermatology)
- Cardizem, including Cardizem CD, Cardizem LA and its generic (high blood pressure)
- Clobetasol spray (dermatology)
- Clobex spray (dermatology)
- Cymbalta (depression)
- Diovan (high blood pressure)
- Exforge, including Exforge HCT (high blood pressure)
- Fluorouracil cream 0.5% (dermatology)
- Fortesta (testosterone replacement)
- Fosrenol (kidney disease)
- Incruse Ellipta (Chronic obstructive pulmonary disease)
- Intuniv (ADHD)
- Invokameet (diabetes)
- Invokana (diabetes)
- Matzim LA (high blood pressure)
- Monovisc (monovisc)
- Noritate (dermatology)
- Qsymia (anti-obesity)
- Relistor (gastrointestinal)
- Valcyte (anti-infective)
- Viagra (erectile dysfunction)
- Zubsolv (opioid dependence)
Comment